封面
市场调查报告书
商品编码
1946930

螺旋卷式膜实验室设备市场(按孔径、膜材料、应用、最终用户、自动化程度和製程压力划分),全球预测,2026-2032年

Spiral-wound Membrane Lab Equipment Market by Pore Size, Membrane Material, Application, End User, Automation Level, Process Pressure - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年螺旋捲膜实验室设备市值为 2.6215 亿美元,预计到 2026 年将成长至 2.8182 亿美元,预计到 2032 年将达到 4.3547 亿美元,复合年增长率为 7.51%。

关键市场统计数据
基准年 2025 2.6215亿美元
预计年份:2026年 2.8182亿美元
预测年份 2032 4.3547亿美元
复合年增长率 (%) 7.51%

全面介绍螺旋捲式膜实验室设备,说明性能驱动因素、实验室工作流程以及过滤在分析和製备科学中的重要性。

在现代实验室中,螺旋捲式膜分离装置在分析精度和製备通量之间发挥着至关重要的作用。这些装置整合了薄膜膜、精密外壳和可控流路,能够实现样品製备流程中必不可少的澄清、海水淡化、蛋白质富集和选择性分离。无论是在科学研究或常规检测环境中,螺旋卷式装置的性能都会影响实验的可重复性、样品的完整性以及后续分析的可靠性。

自动化程度的提高、材料创新、永续性以及研究环境中的数位化流程整合等变革正在重塑螺旋捲膜实验室设备。

由于技术和操作两方面因素的融合,螺旋卷式膜实验室设备领域正经历快速变革时期。自动化和控制系统的进步超越了简单的压力调节,涵盖了整合感测器、封闭回路型监测和资料登录功能,提高了重复性并实现了预测性维护。同时,材料科学的突破使得客製化膜化学成为可能,增强了膜的抗污染性、化学相容性和热稳定性,从而帮助实验室拓展应用范围并减少清洗次数。

2025年美国关税对螺旋薄膜捲绕设备生态系统的供应链、采购决策、零件成本与策略因应措施的累积影响

美国2025年实施的关税调整对螺旋捲膜实验室设备供应链产生了显着影响,迫使各机构重新评估其采购和库存策略。进口膜、外壳和辅助组件关税的提高推高了到岸成本,缩短了即时采购的周期,并促使采购方持有安全库存或重新谈判长期供应合约。因此,我们看到供应商多元化和对采购韧性的重视程度显着提高。

透过孔隙结构、聚合物化学性质、应用流程、终端用户需求、自动化程度和製程压力要求等关键细分洞察,揭示产品差异化。

从核心细分维度对螺旋捲膜实验室设备市场进行细分,可以清楚揭示其性能特征和采购趋势,从而指南产品策略和采购决策。从孔径角度来看,微过滤、奈米过滤、逆渗透和超过滤之间存在差异,每种类型都针对特定的样品类型和分离挑战。实验室会根据目标粒径、处理量要求和允许的跨膜压力来确定孔结构的优先顺序。

影响采购、製造和研发实施的区域趋势和竞争地位(美洲、欧洲、中东和非洲、亚太地区)

区域趋势对螺旋缠绕式实验室设备的製造地、采用率和供应链策略有显着影响。在美洲,需求主要集中在研究机构、生物技术中心和合约检测机构,这些机构优先考虑快速交货、售后服务和合规性支援。这种环境促使供应商维持本地库存和技术支持,以减少停机时间并支持迭代方法开发。

来自领先供应商和新兴专家的企业级观点和创新策略正在推动实验室过滤设备的产品开发、品质保证和分销管道的进步。

螺旋捲膜实验室设备领域的企业活动呈现出传统优势与新兴专业化之间的平衡。成熟的跨国供应商通常凭藉其完善的品质系统、广泛的分销网络和全面的应用支持,服务于製药和食品检测等受监管行业。另一方面,专业製造商则专注于小众膜化学、客製化模组化结构以及为研发密集型客户提供高精度製造服务。新兴参与企业则致力于材料创新、防污涂层或整合电子技术,以实现产品差异化,并在特定应用领域抢占市场份额。

为行业领导者提供实用建议,以优化供应链、加速产品创新、加强品管并敏捷地抓住实验室采购机会

为了在瞬息万变的环境中占据优势,产业领导者应立即采取基于实证的措施,确保供应链安全,加速产品创新,并与实验室工作流程保持一致。首先,透过建立跨区域供应商关係和寻找替代零件製造商来实现采购多元化,对于降低关税波动和物流中断风险至关重要。这项工作应与旨在减少受关税影响的零件和提高模组化程度的设计审查同步进行,从而简化更换供应商时的重新认证流程。

本研究采用透明的调查方法,说明了多模态资料收集、实验室检验、相关人员访谈、专利和技术审查以及分析框架。

本执行摘要的研究采用了多模态调查方法,结合了技术评估、相关人员对话和实证检验。主要研究包括对采购负责人、实验室经理、研发科学家和製造工程师进行结构化访谈,以了解学术界、工业界和监管领域的需求、挑战和实施标准。这些访谈深入分析了产品规格偏好以及采购决策的驱动因素。

全面分析,明确螺旋捲膜实验室设备和工作流程优化相关相关人员的策略要务、新兴风险和切实可行的后续步骤

本概述重点阐述了螺旋捲式膜实验室设备目前面临的战略十字路口。技术创新、监管压力和日益复杂的供应链正在共同重塑采购和产品开发的优先事项。相关人员必须认识到,膜的选择、材料相容性、自动化准备和区域采购决策是相互依存的因素,对实验室的吞吐量、资料完整性和长期营运成本有显着影响。

目录

第一章:序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵,2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章:美国关税的累积影响,2025年

第七章:人工智慧的累积影响,2025年

8. 依孔径分類的螺旋捲式膜实验室设备市场

  • 过滤
  • 奈米过滤
  • 逆渗透
  • 超过滤

9. 螺旋捲式膜实验室设备市场(依膜材料划分)

  • 聚酰胺
  • 聚醚砜
  • 聚砜
  • 聚二氟亚乙烯

第十章 螺旋卷式膜实验室设备市场(依应用领域划分)

  • 澄清
  • 海水淡化
  • 蛋白质浓度
  • 样品製备

第十一章 螺旋捲膜实验室设备市场(依最终用户划分)

  • 学术研究
  • 化学分析
  • 食品/饮料
    • 饮料检验
    • 乳製品分析
  • 製药
    • 分析测试
    • 生物製药

12. 依自动化程度分類的螺旋捲膜实验室设备市场

  • 全自动
  • 手动的
  • 半自动

13. 依製程压力分類的螺旋捲式膜实验室设备市场

  • 高压
  • 低压
  • 中压

第十四章 螺旋捲式膜实验室设备市场(按地区划分)

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 螺旋捲式膜实验室设备市场(依组别划分)

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国螺旋卷式薄膜实验室设备市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章:美国螺旋捲膜实验室设备市场

第十八章 中国螺旋捲膜实验室设备市场

第十九章 竞争情势

  • 市场集中度分析,2025年
    • 浓度比(CR)
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析,2025 年
  • 2025年产品系列分析
  • 基准分析,2025 年
  • 3M Company
  • Amazon Filters Ltd.
  • Aquaporin A/S
  • Cole Parmer Instrument Company LLC
  • Cytiva
  • GE Healthcare Life Sciences
  • Graver Technologies LLC
  • Koch Separation Solutions Inc.
  • Membrane Solutions LLC
  • Merck KGaA
  • Pall Corporation
  • Parker Hannifin Corporation
  • Porvair Filtration Group
  • Repligen Corporation
  • Sartorius AG
  • Sterlitech Corporation
  • Synder Filtration Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-505B17105E7C

The Spiral-wound Membrane Lab Equipment Market was valued at USD 262.15 million in 2025 and is projected to grow to USD 281.82 million in 2026, with a CAGR of 7.51%, reaching USD 435.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 262.15 million
Estimated Year [2026] USD 281.82 million
Forecast Year [2032] USD 435.47 million
CAGR (%) 7.51%

Comprehensive introduction to spiral-wound membrane laboratory equipment emphasizing performance drivers, laboratory workflows, and the critical role of filtration in analytical and preparative sciences

Spiral-wound membrane laboratory equipment occupies a pivotal role at the intersection of analytical fidelity and preparative throughput in modern laboratories. These assemblies integrate thin-film membranes, precise housings, and controlled flow paths to achieve selective separations that are indispensable for clarification, desalting, protein concentration, and sample preparation workflows. In both research and routine testing environments, the performance of spiral-wound devices influences experimental reproducibility, sample integrity, and downstream assay reliability.

Laboratory teams increasingly rely on compact, robust spiral-wound modules to bridge bench-scale experiments and process development. As experiments scale or require iterative purification cycles, the devices' ease of use, cleanability, and compatibility with diverse chemistries become operational priorities. Consequently, product specifications such as membrane chemistry, pore architecture, and pressure tolerance directly affect method development timelines and overall laboratory productivity.

Transitioning from descriptive function to strategic value, procurement and R&D stakeholders must align equipment selection with analytical goals, regulatory constraints, and long-term workflow standardization. This alignment reduces variability across experiments and accelerates time-to-result, while enabling laboratories to respond nimbly to evolving project requirements and cross-disciplinary demands.

Emerging transformative shifts reshaping spiral-wound membrane lab equipment including automation advances, material innovations, sustainability mandates, and digital process integration across research environments

The landscape for spiral-wound membrane laboratory equipment has entered a period of concentrated transformation driven by converging technological and operational forces. Advances in automation and control systems have moved beyond simple pressure regulation to include integrated sensors, closed-loop monitoring, and data logging that enhance reproducibility and enable predictive maintenance. Concurrently, material science breakthroughs deliver tailored membrane chemistries that increase fouling resistance, chemical compatibility, and thermal stability, allowing labs to expand application envelopes and reduce cleaning cycles.

Sustainability mandates have introduced new design imperatives: devices are now evaluated not only on throughput and selectivity, but also on lifecycle impact, recyclability of components, and solvent footprint. Digital process integration has further accelerated adoption by linking membrane performance metrics with laboratory information management systems, enabling real-time decision-making and statistical process control. Additionally, modular product architectures permit rapid reconfiguration for different pore size requirements and process pressures, supporting agile method development and cross-functional collaboration.

Taken together, these shifts reframe the value proposition of spiral-wound lab equipment from a consumable filtration element to a data-enabled platform that supports quality assurance, regulatory traceability, and operational efficiency. Organizations that acknowledge and act on these trends will capture both scientific and commercial advantages.

Cumulative implications of United States tariff actions in 2025 on supply chains, sourcing decisions, component costs, and strategic responses in the spiral-wound membrane equipment ecosystem

Tariff changes implemented in the United States during 2025 have created measurable effects across the supply chain for spiral-wound membrane laboratory equipment, prompting organizations to reassess sourcing and inventory strategies. Increased duties on imported membranes, housings, and ancillary components elevated landed costs and compressed the window for just-in-time procurement, encouraging buyers to hold safety stock or renegotiate long-term supply contracts. The result has been a tangible shift toward supplier diversification and a stronger emphasis on sourcing resiliency.

In response, many suppliers accelerated nearshoring efforts or explored regional production partnerships to mitigate tariff exposure and shorten lead times. These moves often required capital investment and process requalification, but they provided improved responsiveness and reduced logistical complexity. Procurement teams adapted by specifying broader acceptable origins for components and by conducting more rigorous supplier risk assessments that accounted for tariff volatility and geopolitical risk.

The tariff environment also influenced product design choices. Manufacturers optimized bill-of-materials to minimize tariff-liable content by redesigning certain assembly elements, increasing local content where feasible, and prioritizing modularity to ease compliance. For laboratories, the cumulative effect was a period of transitional pricing volatility followed by a gradual stabilization as supply chains rebounded and contractual protections such as tariff clauses and hedging strategies took effect.

Key segmentation insights that decode product differentiation by pore architecture, polymer chemistry, application workflows, end-user demands, automation tiers, and process pressure requirements

Disaggregating the spiral-wound membrane laboratory equipment landscape by core segmentation dimensions reveals distinct performance and purchasing dynamics that inform product strategy and procurement decisions. When viewed through pore size, differentiation exists across microfiltration, nanofiltration, reverse osmosis, and ultrafiltration, with each class serving specific sample types and separation challenges; laboratories prioritize pore architecture according to particle size targets, throughput needs, and acceptable trans-membrane pressures.

Considering membrane material, choices among polyamide, polyethersulfone, polysulfone, and polyvinylidene fluoride reflect trade-offs between chemical compatibility, fouling propensity, mechanical strength, and regulatory acceptability. Application-driven segmentation across clarification, desalting, protein concentration, and sample preparation imposes unique cleanliness requirements and method validation burdens, thereby affecting consumable life cycles and user training needs. End-user categories span academic research, chemical analysis, food and beverage, and pharmaceutical environments; within food and beverage, beverage testing and dairy analysis present different sanitary and throughput expectations, while pharmaceutical users differentiate between analytical testing and biopharmaceutical workflows that demand higher traceability and sterility assurances.

Automation level further stratifies offerings into fully automated, manual, and semi-automated solutions, influencing operator skill requirements and integration complexity. Process pressure classifications into high, low, and medium pressure define equipment design constraints and sealing technologies. By synthesizing these segmentation vectors, stakeholders can match product specifications to operational objectives, prioritize R&D investments, and develop purchasing criteria that reduce lifecycle costs while improving method robustness.

Regional dynamics and competitive positioning across the Americas, Europe Middle East and Africa, and Asia-Pacific with implications for sourcing, manufacturing, and research adoption

Regional dynamics exert a powerful influence on manufacturing footprints, adoption rates, and supply chain strategy for spiral-wound membrane laboratory equipment. In the Americas, demand concentration centers on research institutions, biotechnology hubs, and contract testing facilities that value rapid delivery, after-sales service, and compliance support. This environment has encouraged suppliers to maintain regional inventory and technical support capabilities to reduce downtime and support iterative method development.

The Europe, Middle East & Africa region combines stringent regulatory environments, particularly for pharmaceutical and food testing, with a diverse supplier base that emphasizes certification and environmental compliance. Buyers in this region often prioritize traceability, energy efficiency, and recyclability, prompting manufacturers to demonstrate conformity with regional standards and to provide extended documentation for validation purposes. Meanwhile, Asia-Pacific exhibits strong manufacturing capacity and rapid adoption across industrial and academic sectors; this region's strengths include competitive production costs, fast product iteration cycles, and growing local expertise in polymer science.

Cross-regional considerations include logistics complexity, lead time variability, and differing regulatory expectations, which together shape sourcing strategies. Organizations operating across multiple regions increasingly employ regionalized procurement policies, harmonized specifications, and distributed service networks to maintain consistent performance while managing cost and compliance trade-offs.

Company-level perspectives and innovation strategies from leading suppliers and emerging specialists driving product development, quality assurance, and channel evolution in laboratory filtration

Company-level activity in the spiral-wound membrane laboratory equipment domain reflects a balance of legacy strengths and emergent specialization. Established multinational suppliers typically leverage robust quality systems, broad distribution networks, and extensive application support to serve regulated sectors such as pharmaceuticals and food testing, while specialized fabricators concentrate on niche membrane chemistries, bespoke module geometries, and higher-tolerance manufacturing for research-intensive customers. Emerging entrants frequently focus on material innovation, fouling-resistant coatings, or integrated electronics to differentiate offerings and capture share in application-specific niches.

Strategic partnerships between component manufacturers, instrument OEMs, and academic groups have accelerated product validation cycles and expanded application footprints. These collaborations often yield improved specifications and documentation that ease adoption in regulated environments. Concurrently, firms that invest in service offerings-on-site installation, qualification protocols, and preventive maintenance-demonstrate higher retention with institutional customers because they reduce operational risk and support method transfer.

Competitive dynamics also hinge on supply chain resilience and the ability to adapt to procurement trends driven by tariffs, regionalization, and sustainability requirements. Companies that proactively redesign product bills-of-materials, deepen regional manufacturing capabilities, and offer modular, data-enabled platforms position themselves to capture the next wave of laboratory procurement decisions.

Actionable recommendations for industry leaders to optimize supply chains, accelerate product innovation, tighten quality controls, and capture laboratory procurement opportunities with agility

Industry leaders should take immediate, evidence-based steps to secure supply chains, accelerate product innovation, and align offerings with laboratory workflows to win in a rapidly evolving environment. First, organizations must diversify sourcing by establishing multi-region supplier relationships and qualifying alternate component manufacturers to reduce exposure to tariff fluctuations and logistical disruptions. This action should run in parallel with design reviews aimed at minimizing tariff-liable content and enhancing modularity to simplify requalification when supply sources change.

Second, investing in digital integration and automation will yield measurable gains in reproducibility and operational efficiency; laboratories increasingly reward equipment that interfaces with their data management systems and that supports remote diagnostics. Third, prioritize membrane chemistry and coating research to reduce fouling and expand chemical compatibility, thereby lowering total cost of ownership for end users. Fourth, build robust service and validation portfolios that support regulated industries; documentation, on-site qualification, and preventive maintenance programs increase customer lifetime value and reduce switching risk.

Finally, embed sustainability objectives into product roadmaps by improving component recyclability, reducing solvent consumption during cleaning, and providing end-of-life disposal guidance. By combining supply chain resilience, technical innovation, enhanced service, and sustainability, companies can create defensible differentiation and capture procurement cycles driven by performance, compliance, and total cost considerations.

Transparent research methodology describing multimodal data collection, laboratory validation, stakeholder interviews, patent and technical review, and analytical frameworks used to produce the study

The research underpinning this executive summary used a multimodal methodology that combined technical review, stakeholder engagement, and empirical validation. Primary research included structured interviews with procurement officers, laboratory managers, R&D scientists, and manufacturing engineers to capture requirements, pain points, and adoption criteria across academic, industrial, and regulatory contexts. These conversations provided context for product specification preferences and procurement decision drivers.

Secondary research encompassed technical literature, patent filings, product datasheets, and regulatory guidance to verify material properties, performance claims, and compliance frameworks. Complementing these sources, a review of supplier technical documentation and specification sheets enabled comparative analysis of membrane chemistries, cassette architectures, and pressure ratings. In select cases, laboratory validation of representative assemblies was conducted to assess fouling behavior, cleanability, and pressure-retention characteristics under controlled conditions.

Analytical frameworks included supplier risk scoring, design-of-experiments for material comparisons, and lifecycle assessment principles for sustainability evaluation. Findings were triangulated across sources and subjected to expert validation sessions to ensure robustness and practical relevance for procurement, R&D, and operations stakeholders.

Concluding synthesis that distills strategic imperatives, emergent risks, and practical next steps for stakeholders engaged in spiral-wound membrane laboratory equipment and workflow optimization

This synthesis highlights the strategic crossroads at which spiral-wound membrane laboratory equipment now stands: technological advances, regulatory pressures, and supply chain complexities collectively reshape procurement and product development priorities. Stakeholders must recognize that membrane selection, material compatibility, automation readiness, and regional sourcing decisions are interdependent factors that materially affect laboratory throughput, data integrity, and long-term operational costs.

Organizations that proactively address tariff volatility by diversifying suppliers, regionalizing inventories, and redesigning assemblies for regulatory and fiscal resilience will reduce procurement friction and maintain experimental continuity. Similarly, investing in automation, digital integration, and advanced membrane chemistries will deliver reproducible results and lower total cost of ownership for end users. Service differentiation-through qualification support, preventive maintenance, and documentation-remains a powerful lever to retain institutional customers and reduce procurement friction.

In short, coordinated action across supply chain, R&D, and commercial functions will enable organizations to convert current disruptions into enduring advantages. The near-term priority is to translate strategic insights into operational plans that address risk, enhance product value, and support sustainable laboratory practices.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Spiral-wound Membrane Lab Equipment Market, by Pore Size

  • 8.1. Microfiltration
  • 8.2. Nanofiltration
  • 8.3. Reverse Osmosis
  • 8.4. Ultrafiltration

9. Spiral-wound Membrane Lab Equipment Market, by Membrane Material

  • 9.1. Polyamide
  • 9.2. Polyethersulfone
  • 9.3. Polysulfone
  • 9.4. Polyvinylidene Fluoride

10. Spiral-wound Membrane Lab Equipment Market, by Application

  • 10.1. Clarification
  • 10.2. Desalting
  • 10.3. Protein Concentration
  • 10.4. Sample Preparation

11. Spiral-wound Membrane Lab Equipment Market, by End User

  • 11.1. Academic Research
  • 11.2. Chemical Analysis
  • 11.3. Food And Beverage
    • 11.3.1. Beverage Testing
    • 11.3.2. Dairy Analysis
  • 11.4. Pharmaceutical
    • 11.4.1. Analytical Testing
    • 11.4.2. Biopharmaceutical

12. Spiral-wound Membrane Lab Equipment Market, by Automation Level

  • 12.1. Fully Automated
  • 12.2. Manual
  • 12.3. Semi Automated

13. Spiral-wound Membrane Lab Equipment Market, by Process Pressure

  • 13.1. High Pressure
  • 13.2. Low Pressure
  • 13.3. Medium Pressure

14. Spiral-wound Membrane Lab Equipment Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Spiral-wound Membrane Lab Equipment Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Spiral-wound Membrane Lab Equipment Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Spiral-wound Membrane Lab Equipment Market

18. China Spiral-wound Membrane Lab Equipment Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. 3M Company
  • 19.6. Amazon Filters Ltd.
  • 19.7. Aquaporin A/S
  • 19.8. Cole Parmer Instrument Company LLC
  • 19.9. Cytiva
  • 19.10. GE Healthcare Life Sciences
  • 19.11. Graver Technologies LLC
  • 19.12. Koch Separation Solutions Inc.
  • 19.13. Membrane Solutions LLC
  • 19.14. Merck KGaA
  • 19.15. Pall Corporation
  • 19.16. Parker Hannifin Corporation
  • 19.17. Porvair Filtration Group
  • 19.18. Repligen Corporation
  • 19.19. Sartorius AG
  • 19.20. Sterlitech Corporation
  • 19.21. Synder Filtration Inc.
  • 19.22. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MICROFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MICROFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MICROFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY NANOFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY NANOFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY NANOFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY REVERSE OSMOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY REVERSE OSMOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY REVERSE OSMOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY ULTRAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY ULTRAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY POLYAMIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY POLYAMIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY POLYAMIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY POLYETHERSULFONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY POLYETHERSULFONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY POLYETHERSULFONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY POLYSULFONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY POLYSULFONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY POLYSULFONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY POLYVINYLIDENE FLUORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY POLYVINYLIDENE FLUORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY POLYVINYLIDENE FLUORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY CLARIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY CLARIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY CLARIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY DESALTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY DESALTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY DESALTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROTEIN CONCENTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROTEIN CONCENTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROTEIN CONCENTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY SAMPLE PREPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY SAMPLE PREPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY SAMPLE PREPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY CHEMICAL ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY CHEMICAL ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY CHEMICAL ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY BEVERAGE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY BEVERAGE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY BEVERAGE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY DAIRY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY DAIRY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY DAIRY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY ANALYTICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY ANALYTICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY HIGH PRESSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY HIGH PRESSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY HIGH PRESSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY LOW PRESSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY LOW PRESSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY LOW PRESSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEDIUM PRESSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEDIUM PRESSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEDIUM PRESSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 171. GCC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. GCC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. GCC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. GCC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 178. GCC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 179. GCC SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 198. G7 SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. G7 SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 201. G7 SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. G7 SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. G7 SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 205. G7 SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 206. G7 SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 207. NATO SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. NATO SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 210. NATO SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. NATO SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. NATO SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 214. NATO SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 215. NATO SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA SPIRAL-WOUND MEMBRANE LAB EQUIPMENT MARKET SIZE, BY PROCESS PRESSURE, 2018-2032 (USD MILLION)